STANT
PrivateLast Round
Seed
Nov 19, 2024
Company Overview
STANT is a biotechnology company developing proprietary inhibitors of the STING pathway for the treatment of autoimmune, inflammatory, cardiovascular, metabolic, and neurodegenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
STANT Comparables
Compare STANT with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| iSD Immunotech | 86% | |
| ImmuneSensor Therapeutics | 79% | |
| IFM Therapeutics | 79% |
STANT Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 19, 2024 |
STANT Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Brabantse Ontwikkelings Maatschappij | Seed |
| Brabantse Ontwikkelings Maatschappij | Seed |
| First Fund | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 19, 2024
Seed round with participation from First Fund and Brabantse Ontwikkelings Maatschappij.
STANT Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about STANT's valuation, stock price, and market status.
Is STANT a public or private company?
STANT is a private company.
What is the current stock price of STANT?
STANT is a private company with no public stock price. No recent secondary market data is available.
How much is STANT worth (valuation)?
Valuation information for STANT is not publicly available.
Can I buy STANT stock?
STANT shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was STANT's last funding round?
STANT's most recent funding round was Seed on November 19, 2024.
Who are the main investors in STANT?
Key investors in STANT include Brabantse Ontwikkelings Maatschappij, First Fund.
Will STANT IPO soon?
No public IPO plans have been announced for STANT.
How can I track STANT secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor STANT's secondary market activity and sign up for updates.